InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
T+90 hit rate
67%
T+90 mean return
+5.7%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Eckhardt Sue Gail, Director. Officer active across 2 companies, notably Exelixis, INC.. In total, 12 disclosures have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €1.7m. Activity tracked since 16 September 2022. The latest transaction was disclosed on 27 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations12 total
8,367 shares0Common StockSEC:0000939767-26-000081:0
3,856 shares@ US$43.798.4% of flowCommon StockSEC:0000939767-26-000025
3,856 shares@ US$43.790.0012% mcap8.4% of flowCommon StockSEC:0000939767-26-000025:0
18,834 shares@ US$42.740.0061% mcap41.6% of flowCommon StockSEC:0000939767-25-000099:0
18,834 shares@ US$42.7441.6% of flowCommon StockSEC:0000939767-25-000099
9,812 shares0Common StockSEC:0000939767-25-000087:0
7,712 shares@ US$23.249.2% of flowCommon StockSEC:0000939767-25-000020:0
4,000 shares0Common StockSEC:0000950170-24-070713:0
18,838 shares0Common StockSEC:0000939767-24-000096:0
15,424 shares0Common StockSEC:0000939767-24-000010:0
4,000 shares0Common StockSEC:0001209191-23-033720:0
8,000 shares0Common StockSEC:0001209191-22-050551:0
12 of 12 declarations
About Eckhardt Sue Gail
Eckhardt Sue Gail is a Director at EXELIXIS, INC., a biotechnology company. In her role, she contributes to the strategic direction and oversight of the company's operations. Sue Gail brings significant experience in the sector, thus supporting innovation and growth at EXELIXIS.
